Haemonetics Corp (NYSE:HAE)

CAPS Rating: 5 out of 5

Designs, manufactures and markets automated systems for the collection, processing and surgical salvage of donor and patient blood, including the single-use disposables used with its systems and related information services and data management software.

Results 1 - 11 of 11

Recs

0
Member Avatar Ntoxiphied (< 20) Submitted: 7/28/2010 12:19:38 AM : Outperform Start Price: $27.67 HAE Score: -52.69

Blood... we need it!

Recs

0
Member Avatar Beebzer (88.57) Submitted: 5/12/2009 12:08:12 PM : Outperform Start Price: $25.60 HAE Score: -87.75

building a portfolio of insider cluster buys

Recs

0
Member Avatar hardthinker (62.68) Submitted: 4/13/2009 3:13:58 PM : Outperform Start Price: $25.51 HAE Score: -98.21

Stable defensive growth stock

Recs

0
Member Avatar Afropuffashion (< 20) Submitted: 3/5/2009 1:31:06 PM : Outperform Start Price: $26.55 HAE Score: -165.88

I just think the blood safty industry is a good niche market

Recs

0
Member Avatar WilliamCrook2007 (< 20) Submitted: 11/20/2008 2:54:52 PM : Outperform Start Price: $25.85 HAE Score: -125.61

ibd

Recs

1
Member Avatar goldnmypoc (53.13) Submitted: 3/27/2008 10:33:31 PM : Outperform Start Price: $29.75 HAE Score: -37.44

Steady growth with sales, assets outweigh debt, 10 profitable years, debt definately needs to come down but with the right management this company will continue to do good.

Recs

0
Member Avatar Nanospeed1 (< 20) Submitted: 11/21/2007 7:01:28 PM : Outperform Start Price: $28.23 HAE Score: -19.88

simple business ,exceptional company, great management and products. Something people need, and little competition

Recs

0
Member Avatar lvsenator (< 20) Submitted: 9/3/2007 12:47:15 PM : Outperform Start Price: $24.73 HAE Score: +1.44

steady earnings, innvovative products

Recs

1
Member Avatar dustbusterz (< 20) Submitted: 8/16/2007 12:53:56 PM : Outperform Start Price: $25.54 HAE Score: -13.80

I really don't like the growing net receivables here. . cash flows look ok for now. they have been growing revenue,and most other indicators look good. I'm going out on a limb and predicting that this one can out perform in the next few months but further out ,they will need to pare down the debt a little and the net receivables as well.

Recs

2
Member Avatar XMFIphone (97.91) Submitted: 7/20/2007 10:49:15 AM : Outperform Start Price: $25.48 HAE Score: +3.27

We are always in need of blood and with the baby boomer population reaching an age where they can no longer give blood, and actually need the blood, companies with technologies like Haemonetics are going to be in even more demand as they can help increase the amount of useful blood from each donation. More and more surgeries are requiring transfusions so their patented technology for taking blood from a patient during surgery, cleaning it, and then putting it back into the person is quite revolutionary and can help save lives during surgical procedures. Financially, they have little debt and approximately $8 of cash per share. Plus, their products are always in demand so this company should perform well in any type of economy (hence the low .38 beta).

Recs

4
Member Avatar hybridinvestor (77.85) Submitted: 12/8/2006 8:28:03 PM : Outperform Start Price: $22.55 HAE Score: +8.26

Great pure play blood products manufacturer with basically around 20%+ of the current stock price in cash on hand. Reasonable valuation (not dirt cheap), recent buyback which is the first sign to me they're starting to get more consistent than past results, great balance sheet, and nice possible tuck-in acquisition candidate at some point or even now.

Results 1 - 11 of 11

Featured Broker Partners


Advertisement